Search results
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
The Motley Fool via AOL· 1 day agoAccording to the Centers for Disease Control and Prevention (CDC), available data suggests an increased risk of myocarditis with the Novavax COVID-
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 21 hours ago"Recall that consumer hesitancy regarding Covid boosters has been driven in part by fears about...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 2 days agoNovavax's Covid-19 vaccine is authorized in select geographies under trade names Novavax Covid-19 Vaccine ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoNovavax Reports First Quarter 2024 Financial Results and Operational Highlights PR Newswire GAITHERSBURG, Md., May 10, 2024 Announces co-exclusive licensing agreement with Sanofi to co-commercialize ...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks· 2 days agoBeginning next year, Sanofi will gain rights to co-market Nuvaxovid globally, except in certain countries where Novavax has existing partnership agreements. The French drugmaker ...
Novavax's Q1 Results Are Overshadowed by Its Sanofi Partnership | The Motley Fool
The Motley Fool· 2 days agoNovavax (NVAX 47.63%) released its first-quarter earnings report on May 10, and the vaccine-focused biotechnology company's numbers reflected notable progress. Novavax brings ...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi
Investing.com· 3 days agoThe deal, which includes upfront and milestone payments of around $1.3 billion, half of which is...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 5 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 6 days agoOn the other hand, Novavax's vaccine is differentiated. Whereas the Moderna and Pfizer/BioNTech ...